MYEF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.634800E-01
Normal-vs-Stage2
2.359600E-02
Normal-vs-Stage3
5.080600E-03
Normal-vs-Stage4
1.700770E-01
Stage1-vs-Stage2
2.319600E-01
Stage1-vs-Stage3
9.903500E-02
Stage1-vs-Stage4
3.960800E-01
Stage2-vs-Stage3
1.649010E-01
Stage2-vs-Stage4
6.980600E-01
Stage3-vs-Stage4
1.379590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.902150E-01
Normal-vs-AfricanAmerican
4.311900E-02
Normal-vs-Asian
4.621700E-03
Caucasian-vs-AfricanAmerican
9.472000E-01
Caucasian-vs-Asian
7.275900E-02
AfricanAmerican-vs-Asian
2.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.067440E-01
Normal-vs-Female
2.211000E-01
Male-vs-Female
5.474800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.244400E-01
Normal-vs-Age(41-60Yrs)
3.237600E-01
Normal-vs-Age(61-80Yrs)
9.102200E-02
Normal-vs-Age(81-100Yrs)
4.518700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.612600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.254400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.288800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.527500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.284800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.513000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.178500E-02
Normal-vs-Daily Drinker
1.290770E-01
Normal-vs-Weekly Drinker
1.623870E-02
Normal-vs-Occasional Drinker
6.552600E-01
Normal-vs-Social Drinker
2.639800E-01
Non Drinker-vs-Daily Drinker
8.086200E-01
Non Drinker-vs-Weekly Drinker
9.047200E-01
Non Drinker-vs-Occasional Drinker
2.381400E-01
Non Drinker-vs-Social Drinker
4.448200E-01
Daily Drinker-vs-Weekly Drinker
8.892800E-01
Daily Drinker-vs-Occasional Drinker
2.014400E-01
Daily Drinker-vs-Social Drinker
4.563600E-01
Weekly Drinker-vs-Occasional Drinker
2.223600E-01
Weekly Drinker-vs-Social Drinker
4.671200E-01
Occasional Drinker-vs-Social Drinker
5.565600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.130800E-01
Normal-vs-Grade 2
1.003010E-01
Normal-vs-Grade 3
1.399640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.275910E-02
Grade 1-vs-Grade 3
2.068500E-02
Grade 1-vs-Grade 4
2.130800E-01
Grade 2-vs-Grade 3
7.097800E-01
Grade 2-vs-Grade 4
1.003010E-01
Grade 3-vs-Grade 4
1.399640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.936470E-02
Normal-vs-NonDiabetic
2.259600E-01
Diabetic-vs-NonDiabetic
1.171180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.542100E-03
Normal-vs-NoPancreatitis
1.523830E-01
Pancreatitis-vs-NoPancreatitis
9.034500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.984000E-01
Normal-vs-N1
2.747900E-02
N0-vs-N1
1.314620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.301000E-03
Normal-vs-TP53-NonMutant
6.483800E-01
TP53-Mutant-vs-TP53-NonMutant
1.387750E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
